Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Molecular Devices Forms Scientific Advisory Board

Published: Thursday, December 27, 2012
Last Updated: Thursday, December 27, 2012
Bookmark and Share
Multidisciplinary team will guide product and application development to deliver maximum value to customers.

Molecular Devices, LLC, has announced the formation of its Scientific Advisory Board (SAB).

Comprising experts from a range of fields including stem cell research, biotherapeutics and cell signalling, the SAB will advise on strategy, product applications and product innovation, with the aim of identifying evolving customer needs and ensuring that the Molecular Devices products continue to deliver maximum value.

The SAB has been formed to provide scientific input into new product development, and to keep Molecular Devices focused on customer needs for products that support leading edge research.

These products include systems such as plate readers, imaging systems, or automated electrophysiology platforms, as well as emerging technologies.

Members of the Molecular Devices SAB are:
• Prof Sean J. Morrison, Director of the Children's Research Institute and Mary McDermott Cook Chair in Pediatric Genetics at University of Texas Southwestern, and Investigator of the Howard Hughes Medical Institute.

Prof Morrison is an expert in stem cell biology and the mechanisms by which stem cells are hijacked by cancer cells to enable neoplastic proliferation and metastasis.

• Prof Tobias Meyer, Chair of the Department of Chemical & Systems Biology at Stanford University School of Medicine. Prof Meyer’s areas of expertise are the fields of pharmacology and signal transduction.

His laboratory is developing microscopy and mathematical modeling approaches to understand how cells make decisions and regulate complex processes such as cell proliferation and cell migration.

• Prof Paul Johnston, Associate Professor of the Department of Pharmaceutical Sciences at University of Pittsburgh. Prof Johnston pioneered the use of high content imaging in drug discovery, and is an innovator of cell based approaches for lead generation and optimization. He developed numerous high throughput screening assays and hit assessment campaigns for kinases, transporters, GPCRs and ion channel targets.

• Prof Tobin J. Dickerson, Assistant Professor in the Department of Chemistry at Scripps Research Institute and founding member of the Worm Institute of Research and Medicine (WIRM). Prof Dickerson brings expertise in neural stem cell differentiation, protein-ligand interaction screening, HTS assay development and medicinal chemistry for diagnosis and treatment of chronic infections including the discovery of potent small molecule inhibitors of botulinum neurotoxin.

• Dr Pam Hawley-Nelson, Associate Director for Process Cell Culture at MedImmune. Dr Hawley-Nelson brings 18 years of experience in research and development of novel protein expression technologies, and in the development of cell lines for production of antibody pharmaceuticals.

"We are very pleased to bring together these key thought leaders to establish our Scientific Advisory Board," commented Kevin Chance, President of Molecular Devices.

Chance continued, "Their deep insight into the emerging needs of researchers in the life sciences will be instrumental in directing innovation at Molecular Devices. Securing the interest of and direct interaction with these world class scientists through our SAB reflects the commitment the company has made to being a scientific leader in the market."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Devices Partners with Roche
Partnership will develop custom Ruthenium Nano-TRF Detection Platform.
Thursday, November 06, 2014
Molecular Devices Becomes Global Distributor of IonFlux
Molecular Devices makes deal with Fluxion Biosciences to distribute their automated electrophysiology systems and associated products.
Tuesday, May 28, 2013
Molecular Insight Pharmaceuticals, Inc. Elects a New Board of Directors
The new Board will support the Company’s strategic focus on the discovery, development, and commercialization of radiopharmaceuticals for molecular imaging and targeted radiotherapy of prostate cancer.
Wednesday, February 29, 2012
Molecular Devices to attend ADME & Predictive Toxicology Europe
Company is to showcase its SpectraMax® Paradigm® microplate reader during the European conference in Munich, Germany, 13-14 March 2012.
Wednesday, February 29, 2012
Molecular Devices Awarded Patent for Population Patch Clamp Recording Technique
The parallel recording technique measures ionic currents from a population of cells, rather than single cells, on planar patch clamp systems and enhances ion channel assay success rates to near 100%.
Tuesday, January 10, 2012
Registration opens for RNAi and High Content Imaging 2011
Molecular Devices Inc. announces that they have opened registration for its RNAi & High Content Imaging Symposium 2011, to be held at the Oxford Spires Four Pillars, Oxford on 1st April 2011.
Tuesday, February 08, 2011
Molecular Devices’ RNAi and High Content Imaging Symposium
The RNAi and High Content Imaging Symposium will be discussed at a one day symposium to be held at The Burlington Hotel, Dublin, Ireland, September 16, 2010. The symposium follows the RNAi & miRNA Europe Conference.
Tuesday, September 14, 2010
Molecular Devices Launches New Products & Customer-Focused Brand at Society for Biomolecular Sciences Meeting
New IonWorks Barracuda™ Automated High-Speed Patch Clamp System & AquaMax® 2000/4000 Microplate Washer 96 Cell-Wash Head
Thursday, April 08, 2010
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!